March 2, 2020 / 1:41 AM / a month ago

BRIEF-Sihuan Pharmaceutical Holdings Group Says Clinical Research Of Favipiravir Has Commenced

March 2 (Reuters) - Sihuan Pharmaceutical Holdings Group Ltd :

* CLINICAL RESEARCH OF FAVIPIRAVIR, A DRUG FOR CORONAVIRUS DISEASE HAS COMMENCED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below